76 results on '"D'Costa R"'
Search Results
2. Development of a Prediction Model for Donation after Circulatory Death Lung Donor Progression
- Author
-
Levvey, B.J., primary, Okahara, S., additional, McDonald, M., additional, D'Costa, R., additional, Opdam, H., additional, Pilcher, D., additional, and Snell, G., additional
- Published
- 2021
- Full Text
- View/download PDF
3. Commonly Used Criteria to Initiate Ex-Vivo Lung Perfusion Have No Significant Impact on Early Post Lung-Transplant Outcomes
- Author
-
Okahara, S., primary, Levvey, B., additional, McDonald, M., additional, D'Costa, R., additional, Opdam, H., additional, Pilcher, D., additional, and Snell, G.I., additional
- Published
- 2020
- Full Text
- View/download PDF
4. The Impact of Donor Tobacco and Marijuana Smoking History on Early and Intermediate-Term Lung Transplant Outcomes
- Author
-
Okahara, S., primary, Levvey, B., additional, McDonald, M., additional, D'Costa, R., additional, Opdam, H., additional, Pilcher, D., additional, and Snell, G.I., additional
- Published
- 2020
- Full Text
- View/download PDF
5. Outcome following heart transplantation in Maori and Polynesian patients : a comparison with European New Zealanders
- Author
-
D'Costa, R.
- Published
- 2001
6. The Minimal Leak Test Technique for Endotracheal Cuff Maintenance
- Author
-
Harvie, D. A., primary, Darvall, J. N., additional, Dodd, M., additional, De La Cruz, A., additional, Tacey, M., additional, D'Costa, R. L., additional, and Ward, D., additional
- Published
- 2016
- Full Text
- View/download PDF
7. Factors relating to consent for organ donation: prospective data on potential organ donors
- Author
-
Marck, C. H., primary, Neate, S. L., additional, Skinner, M. R., additional, Dwyer, B. M., additional, Hickey, B. B., additional, D'Costa, R., additional, Weiland, T. J., additional, and Jelinek, G. A., additional
- Published
- 2015
- Full Text
- View/download PDF
8. Haemodynamic studies during the management of severe tetanus
- Author
-
Fe, Udwadia, Jd, Sunavala, Mc, Jain, D'Costa R, Pk, Jain, Lall A, Mallika Sekhar, Zf, Udwadia, Kapadia F, and Kc, Kapur
- Subjects
Adult ,Male ,Tetanus ,Adolescent ,Hemodynamics ,Blood Pressure ,Middle Aged ,Tetanus Antitoxin ,Heart Rate ,Acute Disease ,Humans ,Female ,Vascular Resistance ,Cardiac Output ,Child - Abstract
Detailed invasive haemodynamic studies were performed in 27 of 32 patients with severe tetanus. Nineteen had severe uncomplicated tetanus and eight had associated major complications, chiefly infection and pulmonary complications. The results were compared with those obtained from 15 healthy male volunteers who served as controls. There were two deaths in 32 patients (mortality 6.25 per cent). Severe tetanus without major complications was characterized by a high output hyperkinetic circulatory state with tachycardia (heart rate 131 (19.2) beats/minute), increased stroke volume index (43.1 (10.7) ml/m2), increased cardiac index (5.48 (0.94) l/min/m2) and a normal left ventricular stroke work index (60.5 (15.9) g/m/m2). Volume loading demonstrated a significant haemodynamic response and increased vascular capacitance. Even so the maximum percent rise from baseline values of these indices after volume load was significantly higher in controls (p0.001). Autonomic cardiovascular disturbances affected both sympathetic and parasympathetic activity. Hypertension and tachycardia alternating with hypotension and bradycardia were related to sudden fluctuations in systemic vascular resistance. Our studies suggested some degree of myocardial dysfunction in patients with severe uncomplicated tetanus. The haemodynamics of severe tetanus were masked and altered by complicating infection, pneumonia, and atelectasis.
- Published
- 1992
9. Opioids, Their Receptors, and Pharmacology.
- Author
-
D'Costa, R. A. F. J. and Hanna, Magdi
- Published
- 2013
- Full Text
- View/download PDF
10. Cardiac transplantation in New Zealand maori and polynesian patients
- Author
-
D'Costa, R., primary, Ruygrok, P.N., additional, Coverdale, H.A., additional, Agnew, T.M., additional, Gibbs, H., additional, Reddy, D., additional, Haydock, D.A., additional, and Kerr, A.R., additional
- Published
- 2000
- Full Text
- View/download PDF
11. CAPO with Three 2.5-Liter Exchange V8. Four 2-Liter Exchange
- Author
-
Salahudeen, A. K., primary, D'Costa, R., additional, Pingle, A., additional, and Varma, S. R., additional
- Published
- 1990
- Full Text
- View/download PDF
12. Executorship and Administration of Estates
- Author
-
D'Costa, R. R. and D'Costa, R. R.
- Subjects
- Decedents' estates--Wales, Executors and administrators--England, Executors and administrators--Wales, Decedents' estates--England
- Abstract
This book is an excellent source of practical information relating to the powers, rights and duties of personal representatives responsible for handling an estate. It adopts a problem-solving approach and takes the reader step-by-step through the stage
- Published
- 2001
13. ChemInform Abstract: CHLOROSULPHONATION OF PHTHALIDE AND DERIVATIVES
- Author
-
D'COSTA, R., primary and NADKARNY, V. V., additional
- Published
- 1975
- Full Text
- View/download PDF
14. ChemInform Abstract: CYCLOADDITIONS. XXIX. THE CYCLOADDITION OF VINYLAZIRIDINES WITH UNSATURATED SUBSTRATES
- Author
-
HASSNER, A., primary, CHAU, W., additional, and D'COSTA, R., additional
- Published
- 1982
- Full Text
- View/download PDF
15. ChemInform Abstract: SYNTHESIS OF 2‐PHENYL‐4‐(4′PHENYL‐5′‐MERCAPTO‐1′,2′,4′‐TRIAZOLYL)‐1,2,3‐TRIAZOLES
- Author
-
FERNANDES, P. S., primary, D'COSTA, R., additional, and NADKARNY, V. V., additional
- Published
- 1977
- Full Text
- View/download PDF
16. ChemInform Abstract: STUDIES DIRECTED TOWARD THE SYNTHESIS OF IONOMYCIN(I): SYNTHESIS OF THE FURANOID FRAGMENT
- Author
-
WUTS, P. G. M., primary, D'COSTA, R., additional, and BUTLER, W., additional
- Published
- 1984
- Full Text
- View/download PDF
17. ANAEMIA, FERRITIN, AND VITAMINS IN CONTINUOUS AMBULATORY PERITONEAL DIALYSIS
- Author
-
Salahudeen, A.K., primary, Varma, S.R., additional, Karim, T., additional, Bari, M.Z., additional, Pingle, A., additional, and D'Costa, R., additional
- Published
- 1988
- Full Text
- View/download PDF
18. ChemInform Abstract: NITRATION OF PHTHALIDE
- Author
-
D'COSTA, R., primary and NADKARNY, V. V., additional
- Published
- 1975
- Full Text
- View/download PDF
19. Defects and Demerits of the Double-Bag System
- Author
-
Salahudeen, A.K., primary, D'Costa, R., additional, and Pingle, A., additional
- Published
- 1987
- Full Text
- View/download PDF
20. ChemInform Abstract: SMALL RINGS. 26. CYCLOADDITION OF VINYL AZIRIDINES WITH UNSATURATED SUBSTRATES. A NOVEL REARRANGEMENT OF AN UNSATURATED NITRO COMPOUND
- Author
-
HASSNER, A., primary, D'COSTA, R., additional, MCPHAIL, A. T., additional, and BUTLER, W., additional
- Published
- 1982
- Full Text
- View/download PDF
21. Successful Maastricht Category 5 kidney donation after uncontrolled in-hospital cardiac arrest.
- Author
-
Darvall, J. N., D'Costa, R. L., Rechnitzer, T., and Dale, V. I. B.
- Subjects
- *
CARDIAC arrest , *CARDIAC resuscitation , *RESUSCITATION , *ORGAN donation , *KIDNEY exchange - Abstract
The article discusses a successful Maastricht Category 5 kidney donation following an uncontrolled in-hospital cardiac arrest. It examines the so-called uncontrolled donations from unsuccessful resuscitations and unplanned cardiac arrests that pose concerns about prolonged warm ischaemic time affecting organ viability. It suggests pursuing the option of an uncontrolled kidney donation procedure.
- Published
- 2015
22. Minerva.
- Author
-
Goenka, N, D'Costa, R, and Mahmood, K
- Subjects
- *
PHYSICIANS , *DISEASES , *EMERGENCY medical personnel , *ALZHEIMER'S disease - Abstract
Presents medically-related news briefs. Reflections of a 50 year old emergency physician; Treatment of Alzheimer's disease.
- Published
- 2003
- Full Text
- View/download PDF
23. Haemodynamic Studies During the Management of Severe Tetanus
- Author
-
UDWADIA, FE, SUNAVALA, JD, JAIN, MC, D'COSTA, R, JAIN, PK, LALL, A, SEKHAR, M, UDWADIA, ZF, KAPADIA, F, KAPUR, KC, MEHTA, SK, and KHARAS, RJ
- Abstract
Detailed invasive haemodynamic studies were performed in 27 of 32 patients with severe tetanus. Nineteen had severe uncomplicated tetanus and eight had associated major complications, chiefly infection and pulmonary complications. The results were compared with those obtained from 15 healthy male volunteers who served as controls. There were two deaths in 32 patients (mortality 6.25 per cent). Severe tetanus without major complications was characterized by a high output hyperkinetic circulatory state with tachycardia (heart rate 131 (19.2) beats/minute), increased stroke volume index (43.1 (10.7) ml/m2), increased cardiac index (5.48 (0.94)1/min/m2) and a normal left ventricular stroke work index (60.5 (15.9) g/m/m2). Volume loading demonstrated a significant haemodynamic response and increased vascular capacitance. Even so the maximum percent rise from baseline values of these indices after volume load was significantly higher in controls (p < 0.001). Autonomic cardiovascular disturbances affected both sympathetic and parasympathetic activity. Hypertension and tachycardia alternating with hypotension and bradycardia were related to sudden fluctuations in systemic vascular resistance. Our studies suggested some degree of myocardial dysfunction in patients with severe uncomplicated tetanus. The haemodynamics of severe tetanus were masked and altered by complicating infection, pneumonia, and atelectasis.
- Published
- 1992
24. Towards a Point-Of-Care Multimodal Spectroscopy Instrument for the Evaluation of Human Cardiac Tissue.
- Author
-
Sharma, V., Green, A., Mclean, A., Adegoke, J., Gordon, C., Starkey, G., D'Costa, R., James, F., Afara, I., Lal, S., Wood, B., and Raman, J.
- Subjects
- *
POINT-of-care testing , *SPECTROMETRY , *TISSUES , *HUMAN beings - Published
- 2024
- Full Text
- View/download PDF
25. mTOR signalling controls the formation of smooth muscle cell-derived luminal myofibroblasts during vasculitis.
- Author
-
Stock AT, Parsons S, Hansen JA, D'Silva DB, Starkey G, Fayed A, Lim XY, D'Costa R, Gordon CL, and Wicks IP
- Abstract
The accumulation of myofibroblasts within the intimal layer of inflamed blood vessels is a potentially catastrophic complication of vasculitis, which can lead to arterial stenosis and ischaemia. In this study, we have investigated how these luminal myofibroblasts develop during Kawasaki disease (KD), a paediatric vasculitis typically involving the coronary arteries. By performing lineage tracing studies in a murine model of KD, we reveal that luminal myofibroblasts develop independently of adventitial fibroblasts and endothelial cells, and instead derive from smooth muscle cells (SMCs). Notably, the emergence of SMC-derived luminal myofibroblasts-in both mice and patients with KD, Takayasu's arteritis and Giant Cell arteritis-coincided with activation of the mechanistic target of rapamycin (mTOR) signalling pathway. Moreover, SMC-specific deletion of mTOR signalling, or pharmacological inhibition, abrogated the emergence of luminal myofibroblasts. Thus, mTOR is an intrinsic and essential regulator of luminal myofibroblast formation that is activated in vasculitis patients and therapeutically tractable. These findings provide molecular insight into the pathogenesis of coronary artery stenosis and identify mTOR as a therapeutic target in vasculitis., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
26. The mechanisms underlying conditioning of phantom percepts differ between those with hallucinations and synesthesia.
- Author
-
Del Rio M, Kafadar E, Fisher V, D'Costa R, Powers A, and Ward J
- Subjects
- Humans, Synesthesia, Color Perception, Hallucinations, Caffeine, Perceptual Disorders
- Abstract
There are many different kinds of 'phantom' percepts but it is unknown whether they are united by common mechanisms. For example, synaesthesia (e.g., numbers evoking colour) and hallucinations appear conceptually and phenomenologically similar: both result in a percept that does not have an environmental correlate. Here, people with synaesthesia (n = 66) performed a conditioned hallucinations paradigm known to be sensitive to hallucination susceptibility, and we asked whether synaesthetes would show the same behavioural profile as hallucinators in this task. Repeated pairing of checkerboards with tones, and gratings with colours encourages the participant to draw on prior knowledge when asked to report on the presence of the difficult-to-detect target stimulus. Synaesthetes show increased modelled expectancies for the stimulus association across the board, resulting in a higher number of detections at all stimulus intensities. This is in contrast to the pattern observed in hallucinators, who weigh their prior beliefs more strongly than controls, giving rise to more conditioned hallucinations. Results indicate that fundamentally different perceptual processes may be at the core of these seemingly similar experiences., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
27. Towards a point-of-care multimodal spectroscopy instrument for the evaluation of human cardiac tissue.
- Author
-
Sharma VJ, Green A, McLean A, Adegoke J, Gordon CL, Starkey G, D'Costa R, James F, Afara I, Lal S, Wood B, and Raman J
- Subjects
- Humans, Male, Middle Aged, Female, Spectroscopy, Near-Infrared methods, Point-of-Care Systems, Algorithms, Fibrosis, Cardiomyopathy, Dilated diagnosis, Myocardial Ischemia
- Abstract
To demonstrate that point-of-care multimodal spectroscopy using Near-Infrared (NIR) and Raman Spectroscopy (RS) can be used to diagnose human heart tissue. We generated 105 spectroscopic scans, which comprised 4 NIR and 3 RS scans per sample to generate a "multimodal spectroscopic scan" (MSS) for each heart, done across 15 patients, 5 each from the dilated cardiomyopathy (DCM), Ischaemic Heart Disease (IHD) and Normal pathologies. Each of the MSS scans was undertaken in 3 s. Data were entered into machine learning (ML) algorithms to assess accuracy of MSS in diagnosing tissue type. The median age was 50 years (IQR 49-52) for IHD, 47 (IQR 45-50) for DCM and 36 (IQR 33-52) for healthy patients (p = 0.35), 60% of which were male. MSS identified key differences in IHD, DCM and normal heart samples in regions typically associated with fibrosis and collagen (NIR wavenumbers: 1433, 1509, 1581, 1689 and 1725 nm; RS wavelengths: 1658, 1450 and 1330 cm
-1 ). In principal component (PC) analyses, these differences explained 99.2% of the variation in 4 PCs for NIR, 81.6% in 10 PCs for Raman, and 99.0% in 26 PCs for multimodal spectroscopic signatures. Using a stack machine learning algorithm with combined NIR and Raman data, our model had a precision of 96.9%, recall of 96.6%, specificity of 98.2% and Area Under Curve (AUC) of 0.989 (Table 1). NIR and Raman modalities alone had similar levels of precision at 94.4% and 89.8% respectively (Table 1). MSS combined with ML showed accuracy of 90% for detecting dilated cardiomyopathy, 100% for ischaemic heart disease and 100% for diagnosing healthy tissue. Multimodal spectroscopic signatures, based on NIR and Raman spectroscopy, could provide cardiac tissue scans in 3-s to aid accurate diagnoses of fibrosis in IHD, DCM and normal hearts. Table 1 Machine learning performance metrics for validation data sets of (a) Near-Infrared (NIR), (b) Raman and (c and d) multimodal data using logistic regression (LR), stochastic gradient descent (SGD) and support vector machines (SVM), with combined "stack" (LR + SGD + SVM) AUC Precision Recall Specificity (a) NIR model Logistic regression 0.980 0.944 0.933 0.967 SGD 0.550 0.281 0.400 0.700 SVM 0.840 0.806 0.800 0.900 Stack 0.933 0.794 0.800 0.900 (b) Raman model Logistic regression 0.985 0.940 0.929 0.960 SGD 0.892 0.869 0.857 0.932 SVM 0.992 0.940 0.929 0.960 Stack 0.954 0.869 0.857 0.932 (c) MSS: multimodal (NIR + Raman) to detect DCM vs. IHD vs. normal patients Logistic regression 0.975 0.841 0.828 0.917 SGD 0.847 0.803 0.793 0.899 SVM 0.971 0.853 0.828 0.917 Stack 0.961 0.853 0.828 0.917 (d) MSS: multimodal (NIR + Raman) to detect pathological vs. normal patients Logistic regression 0.961 0.969 0.966 0.984 SGD 0.944 0.967 0.966 0.923 SVM 1.000 1.000 1.000 1.000 Stack 1.000 0.944 0.931 0.969 Bold values indicate values obtained from the stack algorithm and used for analyses., (© 2023. Crown.)- Published
- 2023
- Full Text
- View/download PDF
28. Point-of-care detection of fibrosis in liver transplant surgery using near-infrared spectroscopy and machine learning.
- Author
-
Sharma VJ, Adegoke JA, Fasulakis M, Green A, Goh SK, Peng X, Liu Y, Jackett L, Vago A, Poon EKW, Starkey G, Moshfegh S, Muthya A, D'Costa R, James F, Gordon CL, Jones R, Afara IO, Wood BR, and Raman J
- Abstract
Introduction: Visual assessment and imaging of the donor liver are inaccurate in predicting fibrosis and remain surrogates for histopathology. We demonstrate that 3-s scans using a handheld near-infrared-spectroscopy (NIRS) instrument can identify and quantify fibrosis in fresh human liver samples., Methods: We undertook NIRS scans on 107 samples from 27 patients, 88 from 23 patients with liver disease, and 19 from four organ donors., Results: Liver disease patients had a median immature fibrosis of 40% (interquartile range [IQR] 20-60) and mature fibrosis of 30% (10%-50%) on histopathology. The organ donor livers had a median fibrosis (both mature and immature) of 10% (IQR 5%-15%). Using machine learning, this study detected presence of cirrhosis and METAVIR grade of fibrosis with a classification accuracy of 96.3% and 97.2%, precision of 96.3% and 97.0%, recall of 96.3% and 97.2%, specificity of 95.4% and 98.0% and area under receiver operator curve of 0.977 and 0.999, respectively. Using partial-least square regression machine learning, this study predicted the percentage of both immature ( R
2 = 0.842) and mature ( R2 = 0.837) with a low margin of error (root mean square of error of 9.76% and 7.96%, respectively)., Conclusion: This study demonstrates that a point-of-care NIRS instrument can accurately detect, quantify and classify liver fibrosis using machine learning., Competing Interests: The authors declare no conflict of interest., (© 2023 The Authors. Health Science Reports published by Wiley Periodicals LLC.)- Published
- 2023
- Full Text
- View/download PDF
29. The impact of organ donation specialists on consent rate in challenging organ donation conversations.
- Author
-
Radford S, D'Costa R, Opdam H, McDonald M, Jones D, Bailey M, and Bellomo R
- Abstract
Background: Consent rates for organ donation conversations (ODCs) vary. We hypothesised that a simple grading system could identify challenging ODCs. We further hypothesised that challenging ODCs would have higher consent rates when conducted by ODC specialists. Objectives: We aimed to study the utility of a grading system for ODCs and test the hypothesis that any training effect would be associated with improved consent rates in ODCs graded as most challenging. Methods: We stratified 2017 Australian DonateLife Audit aggregate consent and donation discussion data into four ODC grades based on Australian Organ Donor Register (AODR) status and person first raising the topic of organ donation. Grade I: "yes" present on AODR and family-raised organ donation; Grade II: "yes" present on AODR, and clinician-raised organ donation; Grade III: no registration on AODR but family-raised organ donation; and Grade IV: no registration on AODR, and clinician-raised organ donation. Results: Grade I ODCs were uncommon 7.7% (109/1420), with a consent rate of 95.4% (104/109). Grade IV ODCs were frequent (60.4%, 857/1420), with a consent rate of 41.4% (355/857). However, in Grade IV ODCs, organ donation specialist consent rate was 53.5% (189/353), significantly greater than for other trained staff at 33.1% (88/266) ( P < 0.005; odds ratio [OR], 2.33; 95% CI, 1.68-3.24) or untrained requestors at 32.8% (78/238; P < 0.005; OR, 2.36; 95% CI. 1.68-3.33). Conclusion: The likelihood of consent can be predicted using readily available variables. This allows prospective identification of Grade IV ODCs, which carry low but potentially modifiable likelihood of consent. Involving donation specialists was associated with more consents for organ donation when applied retrospectively to Australian audit data., Competing Interests: None declared., (© 2020 College of Intensive Care Medicine of Australia and New Zealand.)
- Published
- 2023
- Full Text
- View/download PDF
30. Early immune pressure initiated by tissue-resident memory T cells sculpts tumor evolution in non-small cell lung cancer.
- Author
-
Weeden CE, Gayevskiy V, Marceaux C, Batey D, Tan T, Yokote K, Ribera NT, Clatch A, Christo S, Teh CE, Mitchell AJ, Trussart M, Rankin L, Obers A, McDonald JA, Sutherland KD, Sharma VJ, Starkey G, D'Costa R, Antippa P, Leong T, Steinfort D, Irving L, Swanton C, Gordon CL, Mackay LK, Speed TP, Gray DHD, and Asselin-Labat ML
- Subjects
- Humans, Memory T Cells, Immunologic Memory, Lung, CD8-Positive T-Lymphocytes, Carcinoma, Non-Small-Cell Lung genetics, Carcinoma, Non-Small-Cell Lung metabolism, Lung Neoplasms genetics, Lung Neoplasms metabolism
- Abstract
Tissue-resident memory T (T
RM ) cells provide immune defense against local infection and can inhibit cancer progression. However, it is unclear to what extent chronic inflammation impacts TRM activation and whether TRM cells existing in tissues before tumor onset influence cancer evolution in humans. We performed deep profiling of healthy lungs and lung cancers in never-smokers (NSs) and ever-smokers (ESs), finding evidence of enhanced immunosurveillance by cells with a TRM -like phenotype in ES lungs. In preclinical models, tumor-specific or bystander TRM -like cells present prior to tumor onset boosted immune cell recruitment, causing tumor immune evasion through loss of MHC class I protein expression and resistance to immune checkpoint inhibitors. In humans, only tumors arising in ES patients underwent clonal immune evasion, unrelated to tobacco-associated mutagenic signatures or oncogenic drivers. These data demonstrate that enhanced TRM -like activity prior to tumor development shapes the evolution of tumor immunogenicity and can impact immunotherapy outcomes., Competing Interests: Declaration of interests C.S. acknowledges grant support from AstraZeneca, Boehringer-Ingelheim, Bristol-Myers Squibb, Pfizer, Roche-Ventana, Invitae (previously Archer Dx Inc–collaboration in minimal residual disease sequencing technologies), and Ono Pharmaceutical. C.S. is an AstraZeneca Advisory Board member and Chief Investigator for the AZ MeRmaiD 1 and 2 clinical trials and is also Co-Chief Investigator of the NHS Galleri trial funded by GRAIL and a paid member of GRAIL’s SAB. He receives consultant fees from Achilles Therapeutics (also SAB member), Bicycle Therapeutics (also a SAB member), Genentech, Medicxi, Roche Innovation Centre– Shanghai, Metabomed (until July 2022), and the Sarah Cannon Research Institute. He had stock options in Apogen Biotechnologies and GRAIL until June 2021, and currently has stock options in Epic Bioscience, Bicycle Therapeutics, and has stock options and is co-founder of Achilles Therapeutics. C.S. is an inventor on a European patent application relating to assay technology to detect tumour recurrence (PCT/GB2017/053289), the patent has been licensed to commercial entities, and under his terms of employment, C.S. is due a revenue share of any revenue generated from such licence(s). C.S. holds patents relating to targeting neoantigens (PCT/EP2016/059401), identifying patient response to immune checkpoint blockade (PCT/EP2016/071471), determining HLA LOH (PCT/GB2018/052004), predicting survival rates of patients with cancer (PCT/GB2020/050221), identifying patients who respond to cancer treatment (PCT/GB2018/051912), a US patent relating to detecting tumour mutations (PCT/US2017/28013), methods for lung cancer detection (US20190106751A1) and both a European and US patent related to identifying insertion/deletion mutation targets (PCT/GB2018/051892) and is co-inventor to a patent application to determine methods and systems for tumour monitoring (PCT/EP2022/077987). C.S has received honoraria from Amgen, AstraZeneca, Pfizer, Novartis, GlaxoSmithKline, MSD, Bristol Myers Squibb, Illumina, and Roche-Ventana., (Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved.)- Published
- 2023
- Full Text
- View/download PDF
31. Fresh human cardiac tissue for translational research: A novel method of sampling deceased organ donors.
- Author
-
Sharma V, Grant JAL, Gangahanumiah S, Singh A, Gordon CL, James F, D'Costa R, Starkey G, and Raman J
- Published
- 2023
- Full Text
- View/download PDF
32. Mechanistic Target of Rapamycin Inhibition Prevents Coronary Artery Remodeling in a Murine Model of Kawasaki Disease.
- Author
-
Stock AT, Parsons S, D'Silva DB, Hansen JA, Sharma VJ, James F, Starkey G, D'Costa R, Gordon CL, and Wicks IP
- Subjects
- Humans, Animals, Mice, Coronary Vessels pathology, Sirolimus pharmacology, Disease Models, Animal, TOR Serine-Threonine Kinases, Mucocutaneous Lymph Node Syndrome drug therapy, Coronary Artery Disease
- Abstract
Objective: Remodeling of the coronary arteries is a common feature in severe cases of Kawasaki disease (KD). This pathology is driven by the dysregulated proliferation of vascular fibroblasts, which can lead to coronary artery aneurysms, stenosis, and myocardial ischemia. We undertook this study to investigate whether inhibiting fibroblast proliferation might be an effective therapeutic strategy to prevent coronary artery remodeling in KD., Method: We used a murine model of KD (induced by the injection of the Candida albicans water-soluble complex [CAWS]) and analyzed patient samples to evaluate potential antifibrotic therapies for KD., Results: We identified the mechanistic target of rapamycin (mTOR) pathway as a potential therapeutic target in KD. The mTOR inhibitor rapamycin potently inhibited cardiac fibroblast proliferation in vitro, and vascular fibroblasts up-regulated mTOR kinase signaling in vivo in the CAWS mouse model of KD. We evaluated the in vivo efficacy of mTOR inhibition and found that the therapeutic administration of rapamycin reduced vascular fibrosis and intimal hyperplasia of the coronary arteries in CAWS-injected mice. Furthermore, the analysis of cardiac tissue from KD fatalities revealed that vascular fibroblasts localizing with inflamed coronary arteries up-regulate mTOR signaling, confirming that the mTOR pathway is active in human KD., Conclusion: Our findings demonstrate that mTOR signaling contributes to coronary artery remodeling in KD, and that targeting this pathway offers a potential therapeutic strategy to prevent or restrict this pathology in high-risk KD patients., (© 2022 American College of Rheumatology.)
- Published
- 2023
- Full Text
- View/download PDF
33. Australian Donation and Transplantation Biobank: A Research Biobank Integrated Within a Deceased Organ and Tissue Donation Program.
- Author
-
Sharma VJ, Starkey G, D'Costa R, James F, Mouhtouris E, Davis L, Wang BZ, Vago A, Raman J, Mackay LK, Opdam H, Jones R, Grayson ML, Martin DE, and Gordon CL
- Abstract
We aimed to facilitate the donation of tissue samples for research by establishing a centralized system integrated in the organ donation program for collection, storage, and distribution of samples (the Australian Donation and Transplantation Biobank [ADTB])., Methods: Feasibility of a research biobank integrated within the deceased organ and tissue donation program was assessed. DonateLife Victoria sought consent for ADTB donation after consent was received for organ donation for transplantation from the donor's senior available next of kin. ADTB samples were collected during donation surgery and distributed fresh to researchers or stored for future research. The main outcome measures were ADTB donation rates, ADTB sample collection, ADTB sample use, and to identify ethical considerations., Results: Over 2 y, samples were collected for the ADTB from 69 donors (28% of 249 donors). Samples were obtained from the spleen (n = 59, 86%), colon (n = 57, 83%), ileum (n = 56, 82%), duodenum (n = 55, 80%), blood (n = 55, 80%), bone marrow (n = 55, 80%), skin (n = 54, 78%), mesenteric lymph nodes (n = 56, 81%), liver (n = 21, 30%), lung (n = 29, 42%), and lung-draining lymph node (n = 29, 42%). Heart (n = 20), breast (n = 1), and lower urinary tract (n = 1) samples were obtained in the second year. Five hundred fifty-six samples were used in 19 ethics-approved research projects spanning the fields of immunology, microbiology, oncology, anatomy, physiology, and surgery., Conclusions: The integration of routine deceased donation and transplantation activities with a coordinated system for retrieval and allocation of donor samples for use in a range of research projects is feasible and valuable., Competing Interests: The authors declare no conflicts of interest, (Copyright © 2022 The Author(s). Transplantation Direct. Published by Wolters Kluwer Health, Inc.)
- Published
- 2022
- Full Text
- View/download PDF
34. A prediction model to determine the untapped lung donor pool outside of the DonateLife network in Victoria.
- Author
-
Okahara S, Snell GI, Levvey BJ, McDonald M, D'Costa R, Opdam H, and Pilcher DV
- Subjects
- Humans, Lung, Tissue Donors, Victoria, Organ Transplantation, Tissue and Organ Procurement
- Abstract
Lung transplantation is limited by a lack of suitable lung donors. In Australia, the national donation organisation (DonateLife) has taken a major role in optimising organ donor identification. However, the potential outside the DonateLife network hospitals remains uncertain. We aimed to create a prediction model for lung donation within the DonateLife network and estimate the untapped lung donors outside of the DonateLife network. We reviewed all deaths in the state of Victoria's intensive care units using a prospectively collected population-based intensive care unit database linked to organ donation records. A logistic regression model derived using patient-level data was developed to characterise the lung donors within DonateLife network hospitals. Consequently, we estimated the expected number of lung donors in Victorian hospitals outside the DonateLife network and compared the actual number. Between 2014 and 2018, 291 lung donations occurred from 8043 intensive care unit deaths in DonateLife hospitals, while only three lung donations occurred from 1373 ICU deaths in non-DonateLife hospitals. Age, sex, postoperative admission, sepsis, neurological disease, trauma, chronic respiratory disease, lung oxygenation and serum creatinine were factors independently associated with lung donation. A highly discriminatory prediction model with area under the receiver operator characteristic curve of 0.91 was developed and accurately estimated the number of lung donors. Applying the model to non-DonateLife hospital data predicted only an additional five lung donors. This prediction model revealed few additional lung donor opportunities outside the DonateLife network, and the necessity of alternative and novel strategies for lung donation. A donor prediction model could provide a useful benchmarking tool to explore organ donation potential across different jurisdictions, hospitals and transplanting centres.
- Published
- 2022
- Full Text
- View/download PDF
35. Benefits of a Standardized Enteral Feeding Protocol on the Nutrition and Health Outcomes of Very Low Birth Weight Preterm Infants.
- Author
-
D'Costa R, Fucile S PhD, OT (reg), Dickson B RD, Gallipoli A, and Dow KE MD, FRCPC
- Subjects
- Birth Weight, Humans, Infant, Infant, Newborn, Infant, Premature, Infant, Very Low Birth Weight, Outcome Assessment, Health Care, Retrospective Studies, Enteral Nutrition methods, Enterocolitis, Necrotizing
- Abstract
Purpose: To compare nutrition and health outcomes before and after implementing a standardized enteral feeding protocol on nutrition and health outcomes in very low birth weight preterm infants. Methods: A retrospective chart review was performed evaluating preterm infants, born less than 34 weeks gestation and weighing less than 1500 g, before and after the implementation of a standardized enteral feeding protocol. Outcomes included weaning of parenteral nutrition, initiation and advancement of enteral feeds, initiation of human-milk fortifier (HMF), change in weight z -score and neonatal morbidities. Results: Fifty-six infants (30 in pre-group, 26 in post-group) met the inclusion criteria. Infants in the standardized enteral feeding protocol group started enteral feeds earlier ( p = 0.039) and received full HMF fortification at lower weights ( p = 0.033) than those in the pre-group. Fewer days on continuous positive airway pressure ( p = 0.021) and lower rates of bronchopulmonary dysplasia ( p = 0.018) were also observed in the post-group. Weaning of parenteral nutrition and weight z -score were not significantly different between groups. There were no differences in other morbidities. Conclusion: Study results suggest that adopting a standardized enteral feeding protocol may promote early initiation of enteral feeds and fortification.
- Published
- 2022
- Full Text
- View/download PDF
36. Intimal macrophages develop from circulating monocytes during vasculitis.
- Author
-
Stock AT, Parsons S, Sharma VJ, James F, Starkey G, D'Costa R, Gordon CL, and Wicks IP
- Abstract
Objective: Vasculitis is characterised by inflammation of the blood vessels. While all layers of the vessel can be affected, inflammation within the intimal layer can trigger thrombosis and arterial occlusion and is therefore of particular clinical concern. Given this pathological role, we have examined how intimal inflammation develops by exploring which (and how) macrophages come to populate this normally immune-privileged site during vasculitis., Methods: We have addressed this question for Kawasaki disease (KD), which is a type of vasculitis in children that typically involves the coronary arteries. We used confocal microscopy and flow cytometry to characterise the macrophages that populate the coronary artery intima in KD patient samples and in a mouse model of KD, and furthermore, have applied an adoptive transfer system to trace how these intimal macrophages develop., Results: In KD patients, intimal hyperplasia coincided with marked macrophage infiltration of the coronary artery intima. Phenotypic analysis revealed that these 'intimal macrophages' did not express markers of resident cardiac macrophages, such as Lyve-1, and instead, were uniformly positive for the chemokine receptor Ccr2, suggesting a monocytic lineage. In support of this origin, we show that circulating monocytes directly invade the intima via transluminal migration during established disease, coinciding with the activation of endothelial cells lining the coronary arteries., Conclusions: During KD, intimal macrophages develop from circulating monocytes that infiltrate the inflamed coronary artery intima by transluminal migration., Competing Interests: IPW has received funding from CSL and Med‐Immune for research on cytokine antagonists. The remaining authors declare no conflict of interest., (© 2022 The Authors. Clinical & Translational Immunology published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc.)
- Published
- 2022
- Full Text
- View/download PDF
37. An Audit of Lung Donor Pool: Optimal Current Donation Strategies and the Potential of Novel Time-Extended Donation After Circulatory Death Donation.
- Author
-
Okahara S, Levvey B, McDonald M, D'Costa R, Opdam H, Pilcher DV, and Snell GI
- Subjects
- Antiviral Agents, Death, Humans, Lung, Retrospective Studies, Tissue Donors, Hepatitis C, Chronic, Lung Transplantation, Tissue and Organ Procurement
- Abstract
Background: In Australia, increased organ donation and subsequent lung transplantation (LTx) rates have followed enhanced donor identification, referral and management, as well as the introduction of a donation after circulatory death (DCD) pathway. However, the number of patients waiting for LTx still continues to exceed the number of lung donors and the search for further suitable donors is critical., Methods: All 2014-2018 Victorian DonateLife hospital deaths after intensive care unit (ICU) admission were analysed retrospectively to quantify unrecognised lung donors using current criteria, as well as novel time-extended (90 mins-24 hrs post-withdrawal) DCD lung donors., Results: Using standard lung donor eligibility criteria, we identified 473 potential lung donors and a further 122 time-extended DCD potential lung donors among 3,538 patients meeting general eligibility criteria. Detailed review of end-of-life discussions with patient families and the reasons why they were not offered donation revealed several categories of additional lung donors-traditional lung donors missed in current practice (n=2); hepatitis C infected lung donors potentially treatable with direct-acting antivirals (n=14), time-extended DCD lung donors (n=60); donor lungs potentially suitable for transplant with use of ex-vivo lung perfusion (EVLP) (n=7)., Conclusion: While the number of lung donor opportunities missed under existing DonateLife donor identification and management processes was limited, a time-extended DCD lung donation pathway could substantially expand the lung donor pool. The use of hepatitis C infected donors, and the possibility of EVLP to solve donor graft assessment or logistic issues, could also provide small additional lung donor opportunities., (Copyright © 2021 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
38. Lung-resident memory B cells established after pulmonary influenza infection display distinct transcriptional and phenotypic profiles.
- Author
-
Tan HX, Juno JA, Esterbauer R, Kelly HG, Wragg KM, Konstandopoulos P, Alcantara S, Alvarado C, Jones R, Starkey G, Wang BZ, Yoshino O, Tiang T, Grayson ML, Opdam H, D'Costa R, Vago A, Mackay LK, Gordon CL, Masopust D, Groom JR, Kent SJ, and Wheatley AK
- Subjects
- Animals, Female, Humans, Mice, Mice, Inbred C57BL, Mice, Knockout, Mice, Transgenic, Phenotype, Influenza, Human immunology, Lung immunology, Memory B Cells immunology, Orthomyxoviridae Infections immunology
- Abstract
Recent studies have established that memory B cells, largely thought to be circulatory in the blood, can take up long-term residency in inflamed tissues, analogous to widely described tissue-resident T cells. The dynamics of recruitment and retention of memory B cells to tissues and their immunological purpose remains unclear. Here, we characterized tissue-resident memory B cells (B
RM ) that are stably maintained in the lungs of mice after pulmonary influenza infection. Influenza-specific BRM were localized within inducible bronchus-associated lymphoid tissues (iBALTs) and displayed transcriptional signatures distinct from classical memory B cells in the blood or spleen while showing partial overlap with memory B cells in lung-draining lymph nodes. We identified lung-resident markers, including elevated expression of CXCR3, CCR6, and CD69, on hemagglutinin (HA)- and nucleoprotein (NP)-specific lung BRM . We found that CCR6 facilitates increased recruitment and/or retention of BRM in lungs and differentiation into antibody-secreting cells upon recall. Although expression of CXCR3 and CCR6 was comparable in total and influenza-specific memory B cells isolated across tissues of human donors, CD69 expression was higher in memory B cells from lung and draining lymph nodes of human organ donors relative to splenic and PBMC-derived populations, indicating that mechanisms underpinning BRM localization may be evolutionarily conserved. Last, we demonstrate that human memory B cells in lungs are transcriptionally distinct to populations in lung-draining lymph nodes or PBMCs. These data suggest that BRM may constitute a discrete component of B cell immunity, positioned at the lung mucosa for rapid humoral response against respiratory viral infections.- Published
- 2022
- Full Text
- View/download PDF
39. A diverse fibroblastic stromal cell landscape in the spleen directs tissue homeostasis and immunity.
- Author
-
Alexandre YO, Schienstock D, Lee HJ, Gandolfo LC, Williams CG, Devi S, Pal B, Groom JR, Cao W, Christo SN, Gordon CL, Starkey G, D'Costa R, Mackay LK, Haque A, Ludewig B, Belz GT, and Mueller SN
- Subjects
- Animals, Cell Differentiation, Mice, Mice, Inbred C57BL, Mice, Knockout, Mice, Transgenic, T-Lymphocytes immunology, Fibroblasts immunology, Homeostasis immunology, Spleen immunology, Stromal Cells immunology
- Abstract
The spleen is a compartmentalized organ that serves as a blood filter and safeguard of systemic immune surveillance. Labyrinthine networks of fibroblastic stromal cells construct complex niches within the white pulp and red pulp that are important for tissue homeostasis and immune activation. However, the identity and roles of the global splenic fibroblastic stromal cells in homeostasis and immune responses are poorly defined. Here, we performed a cellular and molecular dissection of the splenic reticular stromal cell landscape. We found that white pulp fibroblastic reticular cells (FRCs) responded robustly during acute viral infection, but this program of gene regulation was suppressed during persistent viral infection. Single-cell transcriptomic analyses in mice revealed diverse fibroblast cell niches and unexpected heterogeneity among podoplanin-expressing cells that include glial, mesothelial, and adventitial cells in addition to FRCs. We found analogous fibroblastic stromal cell diversity in the human spleen. In addition, we identify the transcription factor SpiB as a critical regulator required to support white pulp FRC differentiation, homeostatic chemokine expression, and antiviral T cell responses. Together, our study provides a comprehensive map of fibroblastic stromal cell types in the spleen and defines roles for red and white pulp fibroblasts for splenic function and orchestration of immune responses.
- Published
- 2022
- Full Text
- View/download PDF
40. Successful Implementation of an Increased Viral Risk Donor Waiting List for Preconsented Kidney Transplant Candidates in Victoria, Australia.
- Author
-
Lee D, Gramnea I, Seng N, Bruns M, Hudson F, D'Costa R, McEvoy L, Sasadeusz J, O'Leary MJ, Basu G, Kausman JY, Masterson R, Paizis K, Kanellis J, Hughes PD, Goodman DJ, and Whitlam JB
- Abstract
Increased viral risk donors (IVRDs) with increased risk behaviors for blood-borne virus infection and negative nucleic acid testing have a low absolute risk of "window period" infection. Utilization and allocation of IVRD organs differ between jurisdictions., Methods: We examined the characteristics and utilization of deceased donor IVRD kidneys and recipient outcomes within a 2-y period (July 31, 2018-July 31, 2020) postimplementation of a new opt-in allocation pathway for preconsented recipients in Victoria, Australia., Results: Fifty-six kidneys from 31 IVRDs were utilized, comprising 13% of donors. Preconsent rate to accept IVRD kidneys increased to 41% of the waitlist in the 2 y postimplementation, and IVRDs having no kidneys utilized reduced to 0%. Compared with non-IVRD kidneys, kidney offer declines >10 per donor were less likely from IVRDs (3% vs 19%; P < 0.05). IVRDs were younger (median age 36 [IQR 30-44] vs 51 [35-60] y; P < 0.0001), with lower kidney donor profile index (25% [13-40%] vs 57% [29-75%]; P < 0.0001), and less hypertension (0% vs 22%; P < 0.01). Estimated glomerular filtration rate 3 mo post-transplant was superior ( P < 0.01). Injecting drug use (61%) was the most common increased risk behavior. 29% of IVRDs were hepatitis C antibody positive but nucleic acid testing negative. No active infection was detected in any recipient post-transplant., Conclusions: The described opt-in system permits efficient allocation and utilization of kidneys from IVRDs, with superior quality and graft function. Education is crucial to facilitate informed consent and equity of access to this donor pool., Competing Interests: The authors declare no funding or conflicts of interest., (Copyright © 2021 The Author(s). Transplantation Direct. Published by Wolters Kluwer Health, Inc.)
- Published
- 2021
- Full Text
- View/download PDF
41. A Retrospective Review of Declined Lung Donors: Estimating the Potential of Ex Vivo Lung Perfusion.
- Author
-
Okahara S, Levvey B, McDonald M, D'Costa R, Opdam H, Pilcher DV, and Snell GI
- Subjects
- Adult, Extracorporeal Circulation methods, Female, Humans, Male, Middle Aged, Retrospective Studies, Lung Diseases surgery, Lung Transplantation methods, Organ Preservation methods, Perfusion methods, Tissue Donors
- Abstract
Background: Even in the extended-criteria era, the reasons for declining lung donors are not always clear. Furthermore, it has not been determined how many actual declined lungs would be retrieved by ex vivo lung perfusion (EVLP) beyond that already achieved in centers with an existing high utilization rate., Methods: This retrospective study reviewed all lung donor referrals between 2014 and 2018, including detailed formal referrals and preliminary notifications. This study categorized reasons for lung donor non-acceptance and estimated how many declined grafts could have been theoretically retrievable by using EVLP., Results: In total, 966 lung donor candidates were referred, including 313 transplanted donors, 336 declined donors after detailed referrals (group A) and 258 preliminary declined. In group A, the primary reasons for refusal were lung quality issues (49%), general medical issues (25%), and organization issues (26%), combined with secondary reasons in many cases. Main lung quality issues were an extensive smoking history, abnormal chest radiography, and underlying lung disease. Although 73 declined lung donors had indications for EVLP, the retrievable lungs decreased to only 30 cases after considering the details of all clinical contraindications and organizational issues. Nevertheless, 59 intended donation after circulatory death donors did not progress to death after withdrawal of cardiorespiratory support in the required timeframe, and EVLP may have an emerging additional role here., Conclusions: Based on commonly cited criteria for EVLP indication, the number of EVLP retrievable lung donors represented only a small portion of declined donor lungs referred to our center from the state donation network., (Copyright © 2021 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
42. Improving the predictability of time to death in controlled donation after circulatory death lung donors.
- Author
-
Okahara S, Snell GI, McDonald M, D'Costa R, Opdam H, Pilcher DV, and Levvey B
- Subjects
- Brain Death, Death, Humans, Lung, Retrospective Studies, Tissue Donors, Tissue and Organ Procurement
- Abstract
Although the use of donation after circulatory death (DCD) donors has increased lung transplant activity, 25-40% of intended DCD donors do not convert to actual donation because of no progression to asystole in the required time frame after withdrawal of cardiorespiratory support (WCRS). No studies have specifically focussed on DCD lung donor progression. This retrospective study reviewed intended DCD lung donors to make a prediction model of the likelihood of progression to death using logistic regression and classification and regression tree (CART). Between 2014 and 2018, 159 of 334 referred DCD donors were accepted, with 100 progressing to transplant, while 59 (37%) did not progress. In logistic regression, a length of ICU stay ≤ 5 days, severe infra-tentorial brain damage on imaging and use of vasopressin were related with the progression to actual donation. CART modelling of the likelihood of death within 90-minute post-WCRS provided prediction with a sensitivity of 1.00 and positive predictive value of 0.56 in the validation data set. In the nonprogressed DCD group, 26 died within 6 h post-WCRS. Referral received early after ICU admission, with nonspontaneous ventilatory mode, deep coma and severe infra-tentorial damage were relevant predictors. The CART model is useful to exclude DCD donor candidates with low probability of progression., (© 2021 Steunstichting ESOT. Published by John Wiley & Sons Ltd.)
- Published
- 2021
- Full Text
- View/download PDF
43. Common Criteria for Ex Vivo Lung Perfusion Have No Significant Impact on Posttransplant Outcomes.
- Author
-
Okahara S, Levvey B, McDonald M, D'Costa R, Opdam H, Pilcher DV, and Snell GI
- Subjects
- Adult, Extracorporeal Circulation methods, Female, Humans, Male, Middle Aged, Respiratory Insufficiency surgery, Retrospective Studies, Treatment Outcome, Lung Transplantation, Organ Preservation methods, Perfusion methods, Primary Graft Dysfunction prevention & control, Tissue and Organ Procurement methods
- Abstract
Background: Although it is intense in health care resources, by facilitating assessment and reconditioning, ex vivo lung perfusion (EVLP) has the potential to expand the donor pool and improve lung transplant outcomes. However, inclusion criteria used in EVLP trials have not been validated., Methods: This retrospective study from 2014 to 2018 reviewed our local state-based donation organization donor records as well as subsequent recipient outcomes to explore the relation between EVLP indications used in clinical trials and recipient outcomes. The primary outcome was primary graft dysfunction grade 3 at 24 hours, with 30-day mortality and posttransplant survival time as secondary outcomes, compared with univariate and multivariate analysis., Results: From 705 lung donor referrals, 304 lung transplantations were performed (use rate of 42%); 212 of recipients (70%) met at least 1 of the commonly cited EVLP initiation criteria. There was no significant difference in primary graft dysfunction grade 3 or 30-day mortality between recipients with or without an EVLP indication (10.2% versus 7.8%, P = .51; and 2.4% versus 0%, P = .14, respectively). Multivariate analyses showed no significant relationship between commonly cited EVLP criteria and primary graft dysfunction grade 3 or survival time. Recipient outcomes were significantly associated with recipient diagnosis., Conclusions: At least 1 commonly cited criterion for EVLP initiation was present in 70% of the transplanted donors, and yet it did not predict clinical results; acceptable outcomes were seen in both subgroups. To discover the true utility of EVLP beyond good clinical management and focus EVLP on otherwise unacceptable lungs, a reconsideration of EVLP inclusion criteria is required., (Copyright © 2021 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
44. Adaptive immunity to human coronaviruses is widespread but low in magnitude.
- Author
-
Tan HX, Lee WS, Wragg KM, Nelson C, Esterbauer R, Kelly HG, Amarasena T, Jones R, Starkey G, Wang BZ, Yoshino O, Tiang T, Grayson ML, Opdam H, D'Costa R, Vago A, Mackay LK, Gordon CL, Wheatley AK, Kent SJ, and Juno JA
- Abstract
Objectives: Endemic human coronaviruses (hCoVs) circulate worldwide but cause minimal mortality. Although seroconversion to hCoV is near ubiquitous during childhood, little is known about hCoV-specific T-cell memory in adults., Methods: We quantified CD4 T-cell and antibody responses to hCoV spike antigens in 42 SARS-CoV-2-uninfected individuals. Antigen-specific memory T cells and circulating T follicular helper (cTFH) cells were identified using an activation-induced marker assay and characterised for memory phenotype and chemokine receptor expression., Results: T-cell responses were widespread within conventional memory and cTFH compartments but did not correlate with IgG titres. SARS-CoV-2 cross-reactive T cells were observed in 48% of participants and correlated with HKU1 memory. hCoV-specific T cells exhibited a CCR6
+ central memory phenotype in the blood, but were enriched for frequency and CXCR3 expression in human lung-draining lymph nodes., Conclusion: Overall, hCoV-specific humoral and cellular memory are independently maintained, with a shared phenotype existing among coronavirus-specific CD4 T cells. This understanding of endemic coronavirus immunity provides insight into the homeostatic maintenance of immune responses that are likely to be critical components of protection against SARS-CoV-2., Competing Interests: The authors declare no conflict of interest., (© 2021 The Authors. Clinical & Translational Immunology published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology Inc.)- Published
- 2021
- Full Text
- View/download PDF
45. Influence of the donor history of tobacco and marijuana smoking on early and intermediate lung transplant outcomes.
- Author
-
Okahara S, Levvey B, McDonald M, D'Costa R, Opdam H, Pilcher DV, Paul E, and Snell GI
- Subjects
- Adult, Female, Graft Survival, Humans, Male, Middle Aged, Retrospective Studies, Risk Factors, Lung Transplantation methods, Marijuana Smoking adverse effects, Tissue Donors, Tobacco Smoking adverse effects
- Abstract
Background: Donor smoking histories are common in the lung donor pool, which are known to adversely affect post-lung transplant (LTx) outcomes. However, no evidence is available about smoking status (current/former), cumulative dose effect, or the combined effect of tobacco with marijuana., Methods: We retrospectively reviewed our local state-based donation organization records and subsequent LTx recipient outcomes. The primary outcome was 3-year graft survival, with cause of death as secondary outcomes. Univariate and multivariate Cox regression analyses were used to explore smoking status or cumulative dose effect., Results: Between 2014 and 2018, 304 LTxs were performed: 133 (44%) LTxs were from never-smoker donors, 68 (22%) from former-smoker donors, and 103 (34%) from current-smoker donors. Of the current-smoker donors, 48% had a marijuana use history. There was no significant difference in early mortality, although recipients who received transplants from current-smoker donors had a lower 3-year graft survival than those who received transplants from never smokers. Multivariate modeling showed that current tobacco smoking (hazard ratio: 2.13, 95% CI: 1.13-3.99) and a more than 5-year weekly marijuana use (hazard ratio: 2.97, 95% CI: 1.29-6.87) were independent donor factors affecting graft survival. Chronic lung allograft dysfunction accounted for a higher proportion of the causes of death within 3 years after LTx where lungs from current/former smokers were utilized compared with those from never smokers (chronic lung allograft dysfunction-cause mortality: 11%, 7%, 0%, respectively)., Conclusions: More than 50% of LTx donors had smoking histories. Current tobacco use or more than 5-year weekly marijuana smoking history adversely affected 3-year graft survival. Our findings support the importance of obtaining a detailed donor tobacco and marijuana smoking history., (Copyright © 2020 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
46. A 3-year-old boy with worsening respiratory distress.
- Author
-
D'Costa R and Sehgal A
- Published
- 2020
- Full Text
- View/download PDF
47. The hospital-based evaluation of laxative prophylaxis in ICU (HELP-ICU): A pilot cluster-crossover randomized clinical trial.
- Author
-
Hay T, Deane AM, Rechnitzer T, Fetterplace K, Reilly R, Ankravs M, Bailey M, Fazio T, Anstey J, D'Costa R, Presneill JJ, MacIsaac CM, and Bellomo R
- Subjects
- Adult, Aged, Catheterization, Cross-Over Studies, Diarrhea, Enteral Nutrition, Female, Humans, Intensive Care Units, Male, Middle Aged, Pilot Projects, Prospective Studies, Rectum, Respiration, Artificial, Constipation drug therapy, Lactulose administration & dosage, Laxatives adverse effects, Laxatives therapeutic use, Sennosides administration & dosage
- Abstract
Purpose: Prophylactic laxative regimens may prevent constipation but may increase diarrhea and subsequent rectal tube insertion. Our aim was to compare three prophylactic laxative regimens on the rate of rectal tube insertion (primary outcome) and major constipation- or diarrhea-associated complications., Material and Methods: We conducted a cluster-crossover trial. Three pods in a single ICU were each randomized to one of three regimens for four months with rolling cross-over. All mechanically-ventilated and enterally-fed adult patients received either regimen: A) one coloxyl with senna BD from day one; B) two coloxyl with senna +20 ml lactulose BD commencing on day 3; or C) two coloxyl with senna tablets +20 ml lactulose BD commencing on day 6., Results: We enrolled 570 patients (A = 170, B = 205, C = 195) with similar baseline features. Overall, 53 (9.3%) patients received a rectal tube, and insertion rate was not statistically different between the three regimens (A = 12.9%, B = 7.8%, C = 7.7%; p = 0.15). The proportions of patients with other major constipation- or diarrhea-associated complications were similar, as were major patient-centred outcomes., Conclusion: Earlier commencement of a prophylactic coloxyl-based laxative regimen (day 1 or 3) did not affect the rates of complications associated with constipation or diarrhea when compared to delayed introduction (day 6)., (Copyright © 2019. Published by Elsevier Inc.)
- Published
- 2019
- Full Text
- View/download PDF
48. Multicenter, randomized controlled, observer-blinded study of a nitric oxide generating treatment in foot ulcers of patients with diabetes-ProNOx1 study.
- Author
-
Edmonds ME, Bodansky HJ, Boulton AJM, Chadwick PJ, Dang CN, D'Costa R, Johnston A, Kennon B, Leese G, Rajbhandari SM, Serena TE, Young MJ, Stewart JE, Tucker AT, and Carter MJ
- Subjects
- Aged, Ankle Brachial Index, Diabetic Foot pathology, Female, Humans, Male, Microcirculation, Middle Aged, Prospective Studies, Single-Blind Method, Treatment Outcome, Diabetic Foot therapy, Foot blood supply, Free Radical Scavengers metabolism, Free Radical Scavengers therapeutic use, Nitric Oxide metabolism, Nitric Oxide therapeutic use, Wound Healing physiology
- Abstract
The aim of this multicenter, prospective, observer-blinded, parallel group, randomized controlled trial was to assess the safety and efficacy of EDX110, a nitric oxide generating medical device, in the treatment of diabetic foot ulcers in a patient group reflecting "real world" clinical practice compared against optimal standard care. Participants were recruited from ten hospital sites in multidisciplinary foot ulcer clinics. The ulcers were full thickness, with an area of 25-2,500 mm
2 and either a palpable pedal pulse or ankle brachial pressure index > 0.5. Infected ulcers were included. Treatment lasted 12 weeks, or until healed, with a 12-week follow-up period. Both arms were given optimal debridement, offloading and antimicrobial treatment, the only difference being the fixed used of EDX110 as the wound dressing in the EDX110 group. 135 participants were recruited with 148 ulcers (EDX110-75; Control-73), 30% of which were clinically infected at baseline. EDX110 achieved its primary endpoint by attaining a median Percentage Area Reduction of 88.6% compared to 46.9% for the control group (p = 0.016) at 12 weeks in the intention-to-treat population. There was no significant difference between wound size reduction achieved by EDX110 after 4 weeks and the wound size reduction achieved in the control group after 12 weeks. EDX110 was well tolerated. Thirty serious adverse events were reported (12 in the EDX110 group, of which 4 were related to the ulcer; 18 in the control group, of which 10 were related and 1 possibly related to the ulcer), with significant reduction in serious adverse events related to the ulcer in EDX group. There was no significant difference in adverse events. This study, in a real world clinical foot ulcer population, demonstrates the ability of EDX110 to improve healing, as measured by significantly reducing the ulcer area, compared to current best clinical practice., (© 2018 by the Wound Healing Society.)- Published
- 2018
- Full Text
- View/download PDF
49. Do non-body donors understand what the term "Body donation" really means?
- Author
-
Cornwall J, Schafer C, D'Costa R, Lal N, and Nada-Raja S
- Subjects
- Cadaver, Female, Humans, Male, Terminology as Topic, Young Adult, Tissue Donors psychology
- Published
- 2015
- Full Text
- View/download PDF
50. New Zealand university students' knowledge and attitudes to organ and tissue donation.
- Author
-
Cornwall J, Schafer C, Lal N, D'Costa R, and Nada-Raja S
- Subjects
- Adolescent, Decision Making, Female, Humans, Male, New Zealand, Surveys and Questionnaires, Third-Party Consent, Young Adult, Health Knowledge, Attitudes, Practice, Students psychology, Tissue and Organ Procurement, Universities
- Abstract
Aim: Organ and tissue donation (OTD) rates in New Zealand are low compared to many countries. Young adults are 'tomorrow's donors', yet the attitudes and knowledge of this group to OTD have not been examined locally. Such information is relevant to ODT education and clinical engagement., Method: A random sample of University of Otago students (<25 years, permanent New Zealand resident) was surveyed to examine OTD knowledge and attitudes. This included general knowledge, OTD policy (opt-in, opt-out), donation by self, and donation by loved ones. Questions included yes-no, multiple choice, and Likert-type responses. Analyses by sex, demographic characteristics, supportive attitudes to ODT, and University of Otago student profile were performed., Results: 180 responses were gathered (mean age 20.1 years, 67% female, 68% New Zealand European); there were no age or response differences between sexes, participants were generally not representative of the University of Otago student profile. Outcomes indicated limited OTD knowledge, positive support for OTD, and willingness to engage in donation the decision-making process for loved ones. Differences between supportive and non-supportive OTD attitudes was seen for some questions., Conclusion: Findings highlight areas for strategic OTD public engagement and provide details relevant to guiding appropriate clinical interaction in facilitating decisions about OTD.
- Published
- 2015
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.